PEPTIDE VACCINATION AGAINST CANCER TESTIS ANTIGENS IN COMBINATION WITH AZACITIDINE FOR PATIENTS WITH MYELODYSPLASTIC SYNDROME AND ACUTE MYELOID LEUKEMIA: AN ONGOING PHASE I STUDY

被引：0
|
作者：
Holmberg, S. [1 ]
Gang, A. Ortved [1 ]
Svane, I. M. [2 ]
Dufva, I. Hogh [1 ]
Hadrup, S. Reker [3 ]
机构：
[1] Herlev Hosp, Dept Hematol, Herlev, Denmark
[2] Herlev Hosp, Ctr Canc Immune Therapy, Herlev, Denmark
[3] Tech Univ Denmark, Sect Vaccinol & Immunol, Copenhagen, Denmark
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB1915
引用
收藏
页码：771 / 772
页数：2
相关论文
共 50 条
  • [11] A phase I/II study of vorinostat, an oral histone deacetylase inhibitor, in combination with azacitidine in patients with the myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). Initial results of the phase I trial: A New York Cancer Consortium
    Silverman, L. R.
    Verma, A.
    Odchimar-Reissig, R.
    Cozza, A.
    Najfeld, V.
    Licht, J. D.
    Zwiebel, J. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [12] Reduction of Extramedullary Complications in Patients With Acute Myeloid Leukemia/Myelodysplastic Syndrome Treated With Azacitidine
    Shabanova, Iren
    Cada, Michaela
    Johnston, Donna L.
    Abbott, Lesleigh S.
    Leung, Elaine W.
    Schechter, Tal
    Dror, Yigal
    Klaassen, Robert J.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2020, 42 (03) : 170 - 174
  • [13] MONITORING OF THE CYTOGENETIC ALTERATIONS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA/MYELODYSPLASTIC SYNDROME TREATED WITH AZACITIDINE
    De Gusmao, B.
    Campeny, A.
    Perez-Persona, E.
    Oiartzabal, I.
    Ardanaz, M.
    Menchaca, M.
    Mendizabal, A.
    Wong, J.
    Pereda, A.
    de Castro, J.
    HAEMATOLOGICA, 2013, 98 : 582 - 583
  • [14] Combination decitabine, arsenic trioxide, and ascorbic acid for the treatment of myelodysplastic syndrome and acute myeloid leukemia: a phase I study
    Welch, John S.
    Klco, Jeffery M.
    Gao, Feng
    Procknow, Elizabeth
    Uy, Geoffery L.
    Stockerl-Goldstein, Keith E.
    Abboud, Camille N.
    Westervelt, Peter
    DiPersio, John F.
    Hassan, Anjum
    Cashen, Amanda F.
    Vij, Ravi
    AMERICAN JOURNAL OF HEMATOLOGY, 2011, 86 (09) : 796 - 800
  • [15] A Final Report: Phase I/II Study of Sequential Azacitidine and Lenalidomide in Patients with Higher-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)
    DiNardo, Courtney D.
    Daver, Naval
    Jabbour, Elias
    Kadia, Tapan
    Borthakur, Gautam
    Konopleva, Marina
    Pemmaraju, Naveen
    Yang, Hui
    Wei, Yue
    Wierda, William G.
    Bueso-Ramos, Carlos E.
    Patel, Keyur P.
    Cortes, Jorge E.
    Ravandi, Farhad
    Kantarjian, Hagop
    Garcia-Manero, Guillermo
    BLOOD, 2014, 124 (21)
  • [16] A Phase I Study of Vosaroxin Plus Azacitidine for Patients with Myelodysplastic Syndrome
    Jacoby, Meagan A.
    Abboud, Camille N.
    Dipersio, John F.
    Cashen, Amanda F.
    Walter, Matthew J.
    Pizarro, Rigoberto De Jesus
    Uy, Geoffrey L.
    BLOOD, 2015, 126 (23)
  • [17] A Phase I/II Study of Combination of Azacitidine, Venetoclax and Pevonedistat in Patients with Newly-Diagnosed Secondary Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) with Hypomethylating Agent (HMA) Failure
    Ong, Faustine
    Garcia-Manero, Guillermo
    Montalban-Bravo, Guillermo
    Alvarado, Yesid
    Ohanian, Maro
    Konopleva, Marina
    Jabbour, Elias
    Jain, Nitin
    Borthakur, Gautam
    DiNardo, Courtney D.
    Daver, Naval
    Issa, Ghayas C.
    Sasaki, Koji
    Chien, Kelly S.
    Takahashi, Koichi
    Andreeff, Michael
    Muftuoglu, Muharrem
    Delumpa, Ricardo
    Mayor, Ejiroghene
    Loiselle, Christopher
    Waller, Lourdes
    Banks, Glenda
    Kantarjian, Hagop
    Cortes, Jorge E.
    Short, Nicholas
    BLOOD, 2022, 140 : 6206 - 6208
  • [18] A phase I study of pevonedistat, azacitidine, and venetoclax in patients with relapsed/refractory acute myeloid leukemia
    Murthy, Guru Subramanian Guru
    Saliba, Antoine N.
    Szabo, Aniko
    Harrington, Alexandra
    Abedin, Sameem
    Carlson, Karen
    Michaelis, Laura
    Runaas, Lyndsey
    Baim, Arielle
    Hinman, Alex
    Maldonado-Schmidt, Sonia
    Venkatachalam, Annapoorna
    Flatten, Karen S.
    Peterson, Kevin L.
    Schneider, Paula A.
    Litzow, Mark
    Kaufmann, Scott H.
    Atallah, Ehab
    HAEMATOLOGICA, 2024, 109 (09) : 2864 - 2872
  • [19] A Phase I Study of Sequential Azacitidine and Lenalidomide for Elderly Patients with Acute Myeloid Leukemia (AML)
    Pollyea, Daniel A.
    Kohrt, Holbrook E.
    Gallegos, Leonel
    Berube, Caroline
    Coutre, Steven
    Gotlib, Jason
    Liedtke, Michaela
    Mitchell, Beverly S.
    Medeiros, Bruno C.
    BLOOD, 2010, 116 (21) : 1347 - 1347
  • [20] PHASE 1B STUDY OF GLASDEGIB (PF-04449913) IN COMBINATION WITH AZACITIDINE IN PATIENTS WITH HIGHER RISK MYELODYSPLASTIC SYNDROME, OLIGOBLASTIC ACUTE MYELOID LEUKEMIA, OR CHRONIC MYELOMONOCYTIC LEUKEMIA
    Borate, U.
    Smith, B. D.
    Gore, S.
    Zeidan, A.
    Savona, M.
    Savoie, M. L.
    Zhu, N.
    Breems, D.
    Zhang, X.
    Shaik, M. N.
    Rampersad, A.
    Chan, G.
    Woolfson, A.
    Sekeres, M.
    HAEMATOLOGICA, 2016, 101 : 73 - 74
12345